{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001739410","name":"Rallybio Corp","summary":"Rallybio Corp is a clinical-stage biotechnology company focused on developing therapies for severe and rare diseases. Its lead program, RLYB116, is a subcutaneously injected C5 complement inhibitor targeting complement-mediated diseases including PNH, PTR, and APS. RLYB332 is a long-acting matriptase-2 antibody in preclinical development for iron overload diseases. The company is pursuing a merger with Candid, a T-cell engager therapeutics company for autoimmune diseases.","people":[],"products":[{"name":"RLYB116","type":"platform","description":"Once-weekly subcutaneous C5 complement inhibitor (Affibody molecule with albumin binding domain) for complement-mediated diseases including PNH, PTR, and APS."},{"name":"RLYB332","type":"platform","description":"Long-acting matriptase-2 (MTP-2) monoclonal antibody in preclinical development for iron overload diseases such as beta thalassemia and MDS."},{"name":"REV102","type":"platform","description":"ENPP1 inhibitor in preclinical development for hypophosphatasia; sold to Recursion subsidiary in July 2025 for $20 million upfront and milestone."}],"partnerships":[{"partner_name":"Exscientia / Recursion Pharmaceuticals","partnership_type":"development","description":"Joint venture formed in July 2019 for AI-based small molecule drug discovery; Exscientia acquired by Recursion in 2024.","start_date":null},{"partner_name":"AbCellera Biologics","partnership_type":"strategic","description":"Multi-year, multi-target strategic alliance entered December 2022 to discover and develop antibody-based therapeutics for rare diseases.","start_date":null},{"partner_name":"Candid","partnership_type":"acquisition","description":"Agreement and Plan of Merger signed March 1, 2026; Candid is a clinical-stage company with T-cell engager therapeutics for autoimmune diseases.","start_date":null}],"affiliations":[],"origin":{"leaf":"0dc927f69e2a0a2141cd6e7ab6a0a4c011392d23a33b5a0a537f6b2fbc56b6d7","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"bbaf032022bf327a781482fb3a5973b6f93b3f4c94a95ff89e2b46a4c4d39b6c","parent":"5ca5fa37e1d8929f00bbc6ea27fbde207eb734fe16937354a80d845becaa431d","source":"0001628280-26-018261","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}